Once ‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS‐165 DARULIGHT study

British Journal of Clinical Pharmacology, EarlyView.

Source: British Journal of Clinical Pharmacology - November 12, 2018 Category: Drugs & Pharmacology Authors: Minh P. L ê, Marie‐Laure Chaix, François Raffi, Sylvie Chevret, Sébastien Gallien, Christine Katlama, Pierre Delobel, Yazdan Yazdanpanah, Juliette Saillard, Jean‐Michel Molina, Gilles Peytavin, the ANRS‐165 DARULIGHT study group Tags: LETTER TO THE EDITOR Source Type: research